Expansion Into New Modalities — During The Pandemic And Beyond

Supporting both German mRNA-based COVID-19 vaccine developers BioNTech SE and CureVac N.V., Rentschler Biopharma SE has not only expanded into the promising field of RNA manufacturing. In this interview, Federico Pollano, Senior Vice President, Global Business Development, speaks about the company’s recent expansion into the cell and gene therapy market.